RECIST was developed in 2000 by the National Cancer Institute, European Organization for Research and Treatment of Cancer, and National Cancer Institute of Canada, with revision to RECIST 1.1 in 2009 ...

News of the study comes days after it emerged an NHS trial will use AI to interpret MRI scans from men suspected of having ...

President Donald Trump said his administration would try to help save the life of the creator of 'Dilbert' get access to a ...

News of the study comes days after it emerged an NHS trial will use AI to interpret MRI scans from men suspected of having ...

Scott Adams says he is in desperate need of a new prostate cancer drug that he was supposed to start receiving but for delays caused by his ...

To our knowledge, this is the greatest survival benefit, based upon hazard ratio, ever seen in a prostate cancer,” said study presenter Stephen J. Freedland, MD.

A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai and collaborators has shown that directly ...

In a significant policy reversal, the National Institute for Health and Care Excellence (NICE) has recommended abiraterone ...

Find out how the NHS is using AI to diagnose prostate cancer faster, potentially improving outcomes for thousands of men ...

UCSF researchers and clinicians presented innovative research and treatment strategies at the American Society of Radiation Oncology’s 2025 Annual Meeting in San Francisco, which ran from Sept. 27 to ...

Carilion Clinic reached fundraising goals for its seven-story cancer treatment center and is set to offer advanced radiation therapy with a $50 million fundraising goal.